What we do

We support our clients in successfully positioning their products and creating value at all phases of the lifecycle: from development to launch, commercialization and beyond.

Biopharmaceutical companies today need to have a laser focus on clearly defining and flawlessly delivering value to a diverse set of stakeholders (e.g. patients, healthcare professionals, payers), starting at discovery through to commercialization and end-of-exclusivity. Executive Insight supports biopharmaceutical companies across all key phases:

• Shape value early on
  Integrating commercial and customer insights earlier into the new product development process is essential to support early-stage decision making and to maximize launch success. We support early stage activities, for example through therapeutic opportunity and competitive landscape assessments, through integrating the policy, payer, HCP and patient perspective, and through strategic definition of value and positioning to guide the development process.
• Maximize launch success
  A successful product launch in today’s increasingly competitive and regulated marketplace is highly dependent on value-based and science-driven decision making. Success requires a thorough understanding what constitutes value for payers, HCPs and patients, and finding compelling and relevant positioning to successfully differentiate your product and deliver on all stakeholders’ expectations. We support clients in building clear and compelling value stories, exploring and implementing beyond-the-pill strategies, and shaping and optimizing launch strategies that resonate with payers, HCPs and patients, and enable future success. 
• Boost brand and franchise performance
  In today’s highly competitive markets there is often fierce competition, including from generics and biosimilars. To maximize the business opportunity at this stage there is a need to plan early, develop more comprehensive lifecycle management strategies and to continue to differentiate e.g. through product enhancements and services. Ways we support our clients in this phase include defining contracting strategies, proposing strategic approaches to tender shaping, and defining and implementing biosimilar defense strategies.